Irinotecan: all 829 studies that test it
Page 6 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.
- Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205711Phase 2
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsCompletedNCT01183494Phase 1
- A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisCompletedNCT01173497Phase 2
- First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerCompletedNCT01163396Phase 2
- Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT01144988Phase 2
- Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNCT01141244Phase 1
- Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal CancerCompletedNCT01139138Phase 1/2
- FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)CompletedNCT01138904Phase 2
- Paclitaxel and Irinotecan in Advanced Gastric CancerCompletedNCT01136031Phase 1/2
- A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic CancerTerminatedNCT01042028Phase 1/2
- Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsCompletedNCT01030042Phase 3
- Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable GlioblastomaCompletedNCT01022918Phase 2
- A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsCompletedNCT01009073Phase 1
- A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)CompletedNCT00990912Phase 1/2
- Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies (Oratecan-102)CompletedNCT00986843Phase 1
- Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma MultiformeWithdrawnNCT00984438Phase 1/2
- HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to LiverCompletedNCT00980239Phase 1
- Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid MalignanciesCompletedNCT00979563Phase 1
- Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00972881Phase 1/2
- Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal CancerStatus unknownNCT00967655Phase 2
- Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA)CompletedNCT00958386Phase 2
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsCompletedNCT00952003Phase 2
- A Study of NK012 in Patients With Relapsed Small Cell Lung CancerCompletedNCT00951613Phase 2
- A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast CancerCompletedNCT00951054Phase 2
- Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base TherapyCompletedNCT00940758Phase 1
- Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWithdrawnNCT00936832Phase 2
- A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal CarcinomaStatus unknownNCT00931840Phase 2
- A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent GliomasCompletedNCT00921167Phase 2
- Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer PatientsCompletedNCT00875771Phase 2
- A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00874328Phase 1/2
- Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With HepatomaCompletedNCT00861783Phase 1
- Safety Study of ON 01910.Na in Combination With Irinotecan or OxaliplatinCompletedNCT00861328Phase 1
- Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract CancerCompletedNCT00832689Phase 2
- Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS MutationsCompletedNCT00827684Phase 2
- Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00819728Phase 2
- Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)CompletedNCT00817284Phase 2
- Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic CancerCompletedNCT00813163Phase 2
- Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00813072Phase 2
- Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS MutationsCompletedNCT00792363Phase 2
- A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsCompletedNCT00786669Phase 1
- A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaCompletedNCT00762255Phase 1
- Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRCTerminatedNCT00755534Phase 2
- Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic CrcTerminatedNCT00755118Phase 2
- A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade GliomasCompletedNCT00734682Phase 1
- Irinotecan in Treating Asian Patients With Solid TumorsCompletedNCT00731276Phase 1
- Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesCompletedNCT00718757Phase 1
- Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage TreatmentTerminatedNCT00717990Phase 2
- Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid TumorsCompletedNCT00708773Phase 1
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal CancerCompletedNCT00695201Phase 1
- Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal CancerCompletedNCT00689624Phase 2
- Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal CancerTerminatedNCT00681876Phase 2
- Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric CancerCompletedNCT00675194Phase 2
- Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase ITerminatedNCT00671801Phase 1
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
- Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory NeuroblastomaCompletedNCT00644696Phase 1
- Second Line Chemotherapy for S-1 Refractory Advanced Gastric CancerCompletedNCT00639327Phase 2/3
- Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) ExpressionsCompletedNCT00637091Phase 2
- Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular CarcinomaCompletedNCT00635323Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00616785Phase 2
- Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + TemozolomideCompletedNCT00616005Phase 2
- Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IVCompletedNCT00614965Phase 2
- Ph I SU011248 + Irinotecan in Treatment of Pts w MGCompletedNCT00611728Phase 1
- Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal CancerCompletedNCT00601692Phase 1
- Phase I/II Combination With Irinotecan- ErbituxCompletedNCT00594984Phase 1/2
- Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT00576654Phase 1
- Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
- Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
- Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00556413Phase 2
- High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced CancerCompletedNCT00547547Phase 1
- Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung CancerStatus unknownNCT00546130Phase 2
- Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic CancerStatus unknownNCT00544063Phase 1
- Study of NK012 in Patients With Refractory Solid TumorsCompletedNCT00542958Phase 1
- Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal CancerCompletedNCT00540943Phase 1
- Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingCompletedNCT00539877Phase 1
- Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerCompletedNCT00537121Phase 1
- AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNCT00535353Phase 1
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal CancerTerminatedNCT00524186Phase 1
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric CancerCompletedNCT00512681Phase 2
- Second-Line Irinotecan vs. ILF for AGCStatus unknownNCT00509964Phase 2
- Irinotecan (Camptosar) in Patients With Advanced SarcomasCompletedNCT00509860Phase 2
- N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk NeuroblastomaCompletedNCT00509353Phase 1
- Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of IrinotecanStatus unknownNCT00507143Not applicable
- Preoperative Chemoradiotherapy With Cetuximab in Rectal CancerStatus unknownNCT00506844Phase 2
- Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal CancerStatus unknownNCT00506623Phase 2
- Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal CancerStatus unknownNCT00506571Phase 2
- A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal MalignancyStatus unknownNCT00506207Phase 1
- Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerTerminatedNCT00506168Phase 2
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT00483834Phase 2
- A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal CancerCompletedNCT00478634Phase 1
- Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRCCompletedNCT00475293Phase 2
- Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTerminatedNCT00465907Phase 2
- Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard TherapyCompletedNCT00463203Phase 2
- Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasCompletedNCT00463073Phase 2
- Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)CompletedNCT00452634Phase 2
- Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerCompletedNCT00449020Phase 2
- Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric PatientsCompletedNCT00447967Phase 2
- ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerCompletedNCT00436072Phase 1
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryCompletedNCT00416767Phase 2
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the LiverStatus unknownNCT00408551Phase 2